Stock listing
Lang & Schwarz:A14Y65 Penumbra, Inc. Aktie
German listing (Lang & Schwarz) of Penumbra, Inc. · home listing NYSE:PEN
Follow Penumbra, Inc. into a list and get an email when it puts out news.
Home listing price · NYSE:PEN
$319.12 USD -1.48 (-0.5%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NYSE:PEN
- Day range
- $319.02 – $320.32 USDNov 20, 2026
- Volume
- 205,390 sharesNov 20, 2026
- Market cap
- $12.58B USDAt the close on Nov 20, 2026 · price × 39.41M shares outstanding
- 52-week range
- $279.69 – $362.41 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $113.9M USDMedian day 320,174 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE:PEN · Home | $319.12 USD | -1.48 (-0.5%) | 205,390 | $319.91 | $320.32 | $319.02 | $320.60 | Close on Nov 20, 2026 |
| Frankfurt:0P8 | €291.20 EUR | -0.40 (-0.1%) | — | €292.00 | €292.00 | €291.00 | €291.60 | Close on Nov 19, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NYSE:PEN · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $319.12 | -1.48 | -0.5% | $319.91 | $320.32 | $319.02 | 205,390 | |
| $320.60 | +1.49 | +0.5% | $318.58 | $321.19 | $318.58 | 214,376 | |
| $319.11 | -1.51 | -0.5% | $319.47 | $320.60 | $319.05 | 365,962 | |
| $320.62 | -0.29 | -0.1% | $322.00 | $322.00 | $320.06 | 250,366 | |
| $320.91 | +0.14 | 0.0% | $322.00 | $322.00 | $320.63 | 237,582 | |
| $320.77 | -0.95 | -0.3% | $322.78 | $322.78 | $320.25 | 214,257 | |
| $321.72 | +0.26 | +0.1% | $321.00 | $322.24 | $320.28 | 320,174 | |
| $321.46 | -0.39 | -0.1% | $321.37 | $321.60 | $320.21 | 242,364 | |
| $321.85 | +2.64 | +0.8% | $319.00 | $322.90 | $319.00 | 251,267 | |
| $319.21 | -1.90 | -0.6% | $319.03 | $320.72 | $319.03 | 336,706 | |
| $321.11 | -1.34 | -0.4% | $323.80 | $324.76 | $320.28 | 310,516 | |
| $322.45 | +2.43 | +0.8% | $324.30 | $324.38 | $322.20 | 374,284 | |
| $320.02 | -1.32 | -0.4% | $320.40 | $322.11 | $319.92 | 425,772 | |
| $321.34 | +2.39 | +0.7% | $320.00 | $321.58 | $318.55 | 463,515 | |
| $318.95 | -3.02 | -0.9% | $320.56 | $321.83 | $318.32 | 497,721 | |
| $321.97 | +3.66 | +1.1% | $318.86 | $321.97 | $318.86 | 672,756 | |
| $318.31 | -5.73 | -1.8% | $321.04 | $321.16 | $316.35 | 851,272 | |
| $324.04 | -1.18 | -0.4% | $324.70 | $324.91 | $323.89 | 407,831 | |
| $325.22 | +0.83 | +0.3% | $323.88 | $325.58 | $323.88 | 434,141 | |
| $324.39 | -0.57 | -0.2% | $324.96 | $325.33 | $323.88 | 360,025 | |
| $324.96 | +1.40 | +0.4% | $323.50 | $325.50 | $323.50 | 472,551 | |
| $323.56 | -0.78 | -0.2% | $324.46 | $324.46 | $321.97 | 377,749 | |
| $324.34 | +1.93 | +0.6% | $322.99 | $324.64 | $322.43 | 368,832 | |
| $322.41 | +1.55 | +0.5% | $320.30 | $322.87 | $320.30 | 272,635 | |
| $320.86 | -0.34 | -0.1% | $322.80 | $322.80 | $320.15 | 278,699 | |
| $321.20 | +1.08 | +0.3% | $322.13 | $322.17 | $320.09 | 345,435 | |
| $320.12 | +0.11 | 0.0% | $320.41 | $320.42 | $319.25 | 272,341 | |
| $320.01 | -0.95 | -0.3% | $320.93 | $320.99 | $318.26 | 216,894 | |
| $320.96 | +1.56 | +0.5% | $319.91 | $320.97 | $318.97 | 277,220 | |
| $319.40 | +1.88 | +0.6% | $317.06 | $319.53 | $317.06 | 555,297 | |
| $317.52 | +1.17 | +0.4% | $316.61 | $317.52 | $316.53 | 379,359 | |
| $316.35 | -0.70 | -0.2% | $316.62 | $317.74 | $316.32 | 366,187 | |
| $317.05 | -0.06 | 0.0% | $317.10 | $318.01 | $316.87 | 308,413 | |
| $317.11 | -0.44 | -0.1% | $318.23 | $318.47 | $317.10 | 368,274 | |
| $317.55 | -0.45 | -0.1% | $318.37 | $318.37 | $316.78 | 239,680 | |
| $318.00 | -0.34 | -0.1% | $318.38 | $318.93 | $317.92 | 350,523 | |
| $318.34 | -0.52 | -0.2% | $318.51 | $319.19 | $318.24 | 378,219 | |
| $318.86 | -0.32 | -0.1% | $318.73 | $318.98 | $318.14 | 189,852 | |
| $319.18 | +0.29 | +0.1% | $318.91 | $319.33 | $318.11 | 189,478 | |
| $318.89 | -0.83 | -0.3% | $319.28 | $319.61 | $318.17 | 228,148 | |
| $319.72 | +0.28 | +0.1% | $318.98 | $320.27 | $318.33 | 482,954 | |
| $319.44 | +0.05 | 0.0% | $319.46 | $320.26 | $318.40 | 410,633 | |
| $319.39 | +0.61 | +0.2% | $319.80 | $319.80 | $318.49 | 797,922 | |
| $318.78 | +1.18 | +0.4% | $317.38 | $318.78 | $316.77 | 293,927 | |
| $317.60 | -1.27 | -0.4% | $319.19 | $319.19 | $317.50 | 994,495 | |
| $318.87 | +0.47 | +0.1% | $319.20 | $319.20 | $317.95 | 416,077 | |
| $318.40 | -0.03 | 0.0% | $317.30 | $319.33 | $317.30 | 816,975 | |
| $318.43 | -1.43 | -0.4% | $319.97 | $319.97 | $318.18 | 500,842 | |
| $319.86 | +2.13 | +0.7% | $319.30 | $320.31 | $318.65 | 269,558 | |
| $317.73 | -0.05 | 0.0% | $318.54 | $318.54 | $317.59 | 152,618 | |
| $317.78 | -1.79 | -0.6% | $319.38 | $319.38 | $317.62 | 141,326 | |
| $319.57 | +0.31 | +0.1% | $319.35 | $320.90 | $319.21 | 212,689 | |
| $319.26 | -2.91 | -0.9% | $322.61 | $322.61 | $319.18 | 380,769 | |
| $322.17 | +1.03 | +0.3% | $321.00 | $322.72 | $321.00 | 174,065 | |
| $321.14 | -1.66 | -0.5% | $322.89 | $323.70 | $321.14 | 313,873 | |
| $322.80 | +0.22 | +0.1% | $322.48 | $324.55 | $322.48 | 220,280 | |
| $322.58 | -0.52 | -0.2% | $325.00 | $325.00 | $322.19 | 150,763 | |
| $323.10 | +1.42 | +0.4% | $320.99 | $323.84 | $320.97 | 477,149 | |
| $321.68 | +0.68 | +0.2% | $320.83 | $322.25 | $320.83 | 234,126 | |
| $321.00 | -2.05 | -0.6% | $323.00 | $323.13 | $321.00 | 476,704 | |
| $323.05 | -1.32 | -0.4% | $322.00 | $323.59 | $321.89 | 513,090 | |
| $324.37 | +0.62 | +0.2% | $323.70 | $324.86 | $323.32 | 271,581 | |
| $323.75 | -1.43 | -0.4% | $324.91 | $324.91 | $323.42 | 144,267 | |
| $325.18 | +1.42 | +0.4% | $323.87 | $325.66 | $323.87 | 167,123 | |
| $323.76 | -3.08 | -0.9% | $327.12 | $327.12 | $323.76 | 210,043 |
Splits
1 split · NYSE:PEN · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-10 | Consolidation |
- Ticker
- Lang & Schwarz:A14Y65
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Oct 29, 2026
Penumbra, Inc. Reports Third Quarter 2026 Financial Results
Latest deck · Jan 15, 2026
Merger or Acquisition (January 2026)
Merger or acquisition · 11 slides
Latest news
Penumbra, Inc. Reports Third Quarter 2026 Financial Results
Oct 29, 2026
Closed $318.95 (-0.9%) on Oct 30, 2026
Penumbra's CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT)
Oct 20, 2026
Closed $324.34 (+0.6%) on Oct 20, 2026
Penumbra, Inc. Reports Second Quarter 2026 Financial Results
Jul 30, 2026
Closed $321.19 (+0.4%) on Jul 31, 2026
THUNDER Study Demonstrates Penumbra's THUNDERBOLT is Safe and Effective for Stroke Care
Jul 22, 2026
Closed $316.50 (-0.3%) on Jul 22, 2026
First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke
Jul 7, 2026
Closed $318.31 (0.0%) on Jul 7, 2026
Penumbra Expands CAVT for Stroke to Europe with CE Mark for THUNDERBOLT
Jun 15, 2026
Closed $318.21 (-0.2%) on Jun 15, 2026
Penumbra's THUNDERBOLT Receives FDA Clearance - Bringing Computer Assisted Vacuum Thrombectomy Technology to Stroke
Jun 11, 2026
Closed $318.71 (+0.1%) on Jun 12, 2026
Penumbra, Inc. Reports First Quarter 2026 Financial Results
May 6, 2026
Closed $324.65 (+0.1%) on May 7, 2026
New STORM-PE Data Show Computer Assisted Vacuum Thrombectomy with Anticoagulation Resulted in Significantly Better Functional Outcomes at 90 Days Compared to Anticoagulation Alone for Pulmonary Embolism Patients
Apr 13, 2026
Closed $331.48 (+0.5%) on Apr 13, 2026
Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
Feb 25, 2026
Closed $338.67 (-0.3%) on Feb 25, 2026
Penumbra, Inc. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 12 in the last 12 months · 30 in all · newest Oct 29, 2026 · oldest 2025
- Calls
- 23 calls with a replay · 23 with a transcript · latest Nov 5, 2025
- Decks
- 4 decks · latest Jan 15, 2026
Where Penumbra, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:PEN · Home listing | NYSE | United States | USD |
| Tradegate:0P8 | Tradegate | Germany | EUR |
| gettex:0P8 | gettex | Germany | EUR |
| LS Exchange:A14Y65 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A14Y65 · This page | Lang & Schwarz | Germany | EUR |
| BMV:PEN | BMV | Mexico | MXN |
| Stuttgart:0P8 | Stuttgart | Germany | EUR |
| BIVA:PEN | BIVA | Mexico | MXN |
| B3:P2NB34 | B3 | Brazil | BRL |
| BOATS:PEN | BOATS | United States | USD |
| Dusseldorf:0P8 | Dusseldorf | Germany | EUR |
| Frankfurt:0P8 | Frankfurt | Germany | EUR |
| Hamburg:0P8 | Hamburg | Germany | EUR |
| Munich:0P8 | Munich | Germany | EUR |
| Hanover:0P8 | Hanover | Germany | EUR |
| Xetra:0P8 | Xetra | Germany | EUR |
Valuation
P/E 80.1× against a median of 24.9×: 9th lowest of 10 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $11.90B USD
- P/E
- 80.1×
- EV/sales
- 7.6×
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 7.9×
- Gross margin
- 68.0%
- Operating margin
- 12.1%
- Net margin
- 10.1%
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 0.18
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Penumbra, Inc. · NYSE:PEN | US$12.58B | US$11.90B | 80.1× | 7.6× | n/a | 7.9× | 10.1% | 0.0× | 0.18 |
| Zimmer Biomet Holdings, Inc. · NYSE:ZBH | US$19.13B | US$26.24B | 24.9× | 3.1× | 11.6× | 1.5× | 8.9% | 0.6× | 0.40 |
| Coloplast A/S Class B · OMXCOP:COLO_B | US$15.08B | US$18.16B | 33.4× | 4.3× | 10.5× | 7.2× | 10.6% | 1.5× | n/a |
| Shanghai United Imaging Healthcare Co., Ltd. Class A · SSE:688271 | US$14.48B | US$13.77B | 54.1× | 5.9× | n/a | 4.4× | 11.5% | 0.1× | n/a |
| Solventum Corporation · NYSE:SOLV | US$14.36B | US$18.98B | 92.1× | 2.3× | 20.0× | 3.0× | 1.9% | 1.1× | 0.56 |
| Baxter International Inc. · NYSE:BAX | US$13.14B | US$12.00B | n/a | 1.0× | 16.2× | 2.0× | −6.2% | 0.1× | 0.97 |
| Smith & Nephew plc · LSE:SN. | US$12.54B | US$15.58B | 20.1× | 2.5× | 11.4× | 2.4× | 10.1% | 0.7× | n/a |
| The Cooper Companies, Inc. · NASDAQ:COO | US$11.20B | US$13.59B | 19.6× | 3.2× | 14.6× | 1.3× | 13.5% | 0.3× | 0.50 |
| Align Technology, Inc. · NASDAQ:ALGN | US$11.02B | US$9.88B | 22.4× | 2.4× | 11.5× | 2.6× | 11.8% | 0.0× | 1.26 |
| Demant A/S · OMXCOP:DEMANT | US$10.68B | US$13.44B | 47.1× | 4.0× | 17.1× | 6.5× | 6.7% | 1.8× | n/a |
| Insulet Corporation · NASDAQ:PODD | US$9.24B | US$9.62B | 21.5× | 3.0× | 13.9× | 5.8× | 13.5% | 0.6× | 0.53 |
| Median of the others | US$12.84B | US$13.68B | 24.9× | 3.0× | 13.9× | 2.8× | 10.4% | 0.6× | 0.55 |
Forecasts
2 strong buy · 1 buy · 14 hold · Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.
- Price target
- 362.54 USD · Analysts' mean
- EPS, year to Dec 2026
- 4.90 · 11 analysts
- Revenue, year to Dec 2026
- 1.61B · 7 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Adam Elsesser | Chairman and Chief Executive Officer |
| Maggie Yuen | Chief Financial Officer |
| Shruthi Narayan | President |
| Johanna Roberts | Executive Vice President, General Counsel and Secretary |
| Ben Sorci | Executive Vice President, Operations |
| Ben Tompkins | Executive Vice President, Development and Compliance |
| Jason Mills | Executive Vice President, Strategy |
| James F. Benenati | Chief Medical Officer |
| Lambert Shiu | Chief Accounting Officer |
Board
| Director | Role |
|---|---|
| Adam Elsesser | Chairman and Chief Executive Officer |
| Arani Bose | Director |
| Bridget O'Rourke | Director |
| Harpreet Grewal | Director |
| Janet Leeds | Director |
| Surbhi Sarna | Director |
| Thomas C. Wilder | Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| Penumbra (NYSE:PEN) Q3 2025 Earnings Call | Wed, Nov 05, 2025 · 4:30 PM ET | Replay |
| Penumbra (NYSE:PEN) Q2 2025 Earnings Call | Tue, Jul 29, 2025 · 4:30 PM ET | Replay |
| Penumbra (NYSE:PEN) Q1 2025 Earnings Call | Wed, Apr 23, 2025 · 4:30 PM ET | Replay |
| Penumbra (NYSE:PEN) Q4 2024 Earnings Call | Tue, Feb 18, 2025 · 4:30 PM ET | Replay |
| Penumbra (NYSE:PEN) Q3 2024 Earnings Call | Wed, Oct 30, 2024 · 4:30 PM ET | Replay |
| Penumbra (NYSE:PEN) Q2 2024 Earnings Call | Tue, Jul 30, 2024 · 4:30 PM ET | Replay |
| Penumbra (NYSE:PEN) Q1 2024 Earnings Call | Tue, May 07, 2024 · 4:30 PM ET | Replay |
| Penumbra (NYSE:PEN) Q4 2023 Earnings Call | Thu, Feb 22, 2024 · 4:30 PM ET | Replay |
| Penumbra (NYSE:PEN) Q3 2023 Earnings Call | Thu, Nov 02, 2023 · 4:30 PM ET | Replay |
| Penumbra (NYSE:PEN) Q2 2023 Earnings Call | Tue, Aug 01, 2023 · 4:30 PM ET | Replay |
All 23 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Oct 29, 2026 · After close | −0.9% |
| Q2 2026 | Jul 30, 2026 · After close | +0.4% |
| Q1 2026 | May 6, 2026 · After close | +0.1% |
| Q4 2025 | Feb 25, 2026 | +0.7% |
| Q3 2025 | Nov 5, 2025 · After close | +17.3% |
| Q2 2025 | Jul 29, 2025 · After close | +11.9% |
| Q1 2025 | Apr 23, 2025 · After close | +7.0% |
| Q4 2024 | Feb 20, 2025 · Before open | −0.2% |
| Q3 2024 | Oct 30, 2024 · After close | +8.3% |
| Q2 2024 | Jul 30, 2024 · After close | −3.5% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 7, 2024 · After close | −3.3% |
| Q4 2023 | Feb 22, 2024 · After close | −9.3% |
| Q3 2023 | Nov 2, 2023 · After close | −0.2% |
| Q2 2023 | Aug 1, 2023 · After close | −9.7% |
| Q1 2023 | May 2, 2023 · After close | +7.0% |
| Q4 2022 | Feb 23, 2023 · After close | +2.2% |
| Q3 2022 | Nov 3, 2022 · After close | +6.7% |
| Q2 2022 | Aug 4, 2022 · After close | +16.6% |
| Q1 2022 | May 3, 2022 · After close | −1.9% |
| Q4 2021 | Feb 22, 2022 · After close | −5.8% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (January 2026) | Merger or acquisition | 11 slides | Jan 15, 2026 |
| VIVA 2025 | Conference | 21 slides | November 2025 |
| Technical Presentation (October 2025) | Technical | 21 slides | October 2025 |
| 42nd Annual J.P. Morgan Healthcare Conference (January 2024) | Conference | 19 slides | January 2024 |
IPO
Priced at US$30.00 a share on Sep 17, 2015.
- Price
- US$30.00 a share
- Shares offered
- 4,000,000 shares of common stock
- Offering size
- US$120 million
- Underwriters' option
- Up to 600,000 more shares
- Underwriters
- J.P. Morgan, BofA Merrill Lynch, Wells Fargo Securities, Canaccord Genuity · In the order on the cover
- Shares delivered
- On or about Sep 23, 2015
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jun 9, 2015 |
| Filed publicly | Aug 14, 2015 |
| Amended 3 times | Newest Sep 15, 2015 |
| Shares registered with an exchange | Sep 15, 2015 |
| Declared effective by the SEC | Sep 17, 2015 |
| Final prospectus, with the price | Sep 18, 2015 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Sep 18, 2015 |
| EFFECT · Notice that a registration is effective | Sep 17, 2015 |
| S-1MEF · Registration of more shares for the same offering | Sep 17, 2015 |
| CERTNYS · New York Stock Exchange's certificate of listing | Sep 15, 2015 |
| 8-A12B · Registration of shares for listing on an exchange | Sep 15, 2015 |
| CORRESP · Letter to the SEC | Sep 15, 2015 |
| CORRESP · Letter to the SEC | Sep 15, 2015 |
| S-1/A · Registration statement, amended | Sep 15, 2015 |
| S-1/A · Registration statement, amended | Sep 8, 2015 |
| UPLOAD · Letter from the SEC | Sep 3, 2015 |
All 21 filings
| Filing | Filed |
|---|---|
| S-1/A · Registration statement, amended | Aug 31, 2015 |
| UPLOAD · Letter from the SEC | Aug 28, 2015 |
| S-1 · Registration statement | Aug 14, 2015 |
| UPLOAD · Letter from the SEC | Aug 12, 2015 |
| DRSLTR · Letter to the SEC with a draft | Jul 29, 2015 |
| DRS/A · Draft registration statement, amended | Jul 29, 2015 |
| UPLOAD · Letter from the SEC | Jul 24, 2015 |
| DRSLTR · Letter to the SEC with a draft | Jul 10, 2015 |
| DRS/A · Draft registration statement, amended | Jul 10, 2015 |
| UPLOAD · Letter from the SEC | Jul 6, 2015 |
| DRS · Draft registration statement | Jun 9, 2015 |
Open IPO · From the cover of the final prospectus (424B4) filed Sep 18, 2015
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.40B | 1.19B | 1.06B | 847.1M | 747.6M | 560.4M | 547.4M | 444.9M | 333.8M | 263.3M |
| Cost of revenue | 461.2M | 439.6M | 375.9M | 311.9M | 272.2M | 222.2M | 175.4M | 152.4M | 116.6M | 92.5M |
| Gross profit | 942.4M | 755.0M | 682.6M | 535.2M | 475.4M | 338.2M | 372.0M | 292.5M | 217.1M | 170.8M |
| Research and development | 89.8M | 94.8M | 84.4M | 79.4M | 104.6M | 90.0M | 51.7M | 36.2M | 31.7M | 23.9M |
| Selling, general and administrative | 663.4M | 574.0M | 506.5M | 449.7M | 378.3M | 287.1M | 272.7M | 226.4M | 184.3M | 148.3M |
| Operating income | 189.2M | 9.28M | 73.6M | 6.08M | -7.50M | -38.9M | 47.5M | -852.0K | 1.17M | -1.35M |
| Depreciation and amortization | 17.5M | 23.7M | 27.3M | 24.3M | 16.4M | 12.9M | 8.10M | 6.17M | 3.78M | 2.30M |
| EBITDA | 206.7M | 33.0M | 100.8M | 30.4M | 8.91M | -26.1M | 55.6M | 5.32M | 4.95M | 947.0K |
| Interest expense | 1.31M | 1.42M | 1.74M | 1.75M | 1.93M | |||||
| Income before tax | 205.1M | 20.9M | 79.7M | 3.89M | -10.5M | -38.0M | 50.1M | 1.61M | 2.48M | -869.0K |
| Income tax | 27.4M | 6.86M | -11.3M | 5.89M | -13.1M | -18.8M | 3.13M | -4.40M | -3.61M | -15.7M |
| Net income | 177.7M | 14.0M | 91.0M | -2.00M | 5.28M | -15.7M | 48.5M | 6.60M | 4.66M | 14.8M |
| Earnings per share, basic | 4.57 | 0.36 | 2.37 | -0.05 | 0.14 | -0.44 | 1.39 | 0.19 | 0.14 | 0.49 |
| Earnings per share, diluted | 4.52 | 0.36 | 2.32 | -0.05 | 0.14 | -0.44 | 1.34 | 0.18 | 0.13 | 0.44 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 186.9M | 324.4M | 167.5M | 69.9M | 59.4M | 69.7M | 72.8M | 67.8M | 50.6M | 13.2M |
| Short-term investments | 357.9M | 15.7M | 121.7M | 118.2M | 195.5M | 195.2M | ||||
| Receivables | 190.0M | 167.7M | 201.8M | 203.4M | 133.9M | 114.6M | 105.9M | 81.9M | 58.0M | 43.3M |
| Inventory | 431.5M | 406.7M | 388.0M | 334.0M | 263.5M | 219.5M | 153.0M | 115.7M | 94.9M | 73.0M |
| Current assets | 1.22B | 951.1M | 915.4M | 755.7M | 681.5M | 617.7M | 463.1M | 410.7M | 382.2M | 263.8M |
| Property, plant and equipment | 117.4M | 62.6M | 72.7M | 65.0M | 58.9M | 48.2M | 51.8M | 35.4M | 30.9M | 21.5M |
| Goodwill | 166.8M | 165.8M | 166.3M | 166.0M | 166.4M | 8.37M | 7.66M | 7.81M | 8.18M | 0 |
| Total assets | 1.83B | 1.53B | 1.56B | 1.37B | 1.24B | 823.0M | 665.9M | 515.0M | 476.7M | 308.3M |
| Accounts payable | 34.7M | 31.3M | 27.2M | 26.7M | 13.4M | 14.1M | 15.1M | 8.18M | 6.76M | 4.11M |
| Current liabilities | 183.1M | 158.3M | 151.1M | 144.9M | 123.2M | 105.9M | 91.0M | 66.1M | 51.6M | 35.8M |
| Total liabilities | 398.9M | 382.3M | 377.4M | 372.0M | 290.3M | 185.2M | 180.3M | 92.6M | 76.3M | 41.7M |
| Shareholders' equity | 1.43B | 1.15B | 1.18B | 998.9M | 953.9M | 641.5M | 485.9M | 422.2M | 400.4M | 266.5M |
| Shares outstanding | 39.2M | 38.5M | 38.7M | 38.1M | 37.6M | 36.4M | 35.0M | 34.4M | 33.7M | 31.1M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 238.7M | 168.5M | 97.3M | -55.7M | 9.50M | -33.2M | 26.7M | 28.8M | 12.7M | -12.8M |
| Capital spending | -63.7M | -21.2M | -15.2M | -19.3M | -21.2M | -24.8M | -22.1M | -9.60M | -12.5M | -13.6M |
| Free cash flow | 174.9M | 147.3M | 82.1M | -75.0M | -11.7M | -58.0M | 4.54M | 19.2M | 159.0K | -26.4M |
| Cash from investing | -404.6M | 77.6M | -16.1M | 54.8M | -21.7M | -104.1M | -12.7M | -385.0K | -77.7M | 687.0K |
| Cash from financing | 26.5M | -87.0M | 16.2M | 11.6M | 836.0K | 134.9M | -8.96M | -9.81M | 104.4M | 7.13M |
| Share buybacks | 0 | -100.4M | 0 | 0 | ||||||
| Change in cash | -137.5M | 156.9M | 97.6M | 10.5M | -10.3M | -3.11M | 4.93M | 17.2M | 37.4M | -6.31M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 17, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 6, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Oct 29, 2026 | Quarterly report | SEC |
| 8-K · Current report | Oct 29, 2026 | Results | SEC |
| 4 · Change in ownership | Oct 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 19, 2026 | Insider trade | SEC |
| SCHEDULE 13G · Big-stake notice | Aug 13, 2026 | Big-stake notice | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 10-Q · Quarterly report | Jul 30, 2026 | Quarterly report | SEC |
| 8-K · Current report | Jul 30, 2026 | Results | SEC |
| 8-K · Current report | Jun 22, 2026 | Meeting outcome | SEC |
| SD · Specialized disclosure | May 29, 2026 | ESG report | SEC |
| 4 · Change in ownership | May 21, 2026 | Insider trade | SEC |
| 425 | May 7, 2026 | Other filings | SEC |
| 8-K · Current report | May 7, 2026 | Meeting outcome | SEC |
| 10-Q · Quarterly report | May 6, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 6, 2026 | Results | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 30, 2026 | Big-stake notice | SEC |
| ARS · Annual report to shareholders | Apr 29, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 29, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 29, 2026 | Meeting notice | SEC |
| 425 | Apr 23, 2026 | Other filings | SEC |
| 425 | Apr 22, 2026 | Other filings | SEC |
| 425 | Apr 17, 2026 | Other filings | SEC |
| 4 · Change in ownership | Apr 6, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Apr 2, 2026 | Other filings | SEC |
| DEFM14A | Apr 1, 2026 | Meeting notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 27, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2026 | Insider trade | SEC |
| 425 | Mar 3, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 2, 2026 | Other filings | SEC |
| 10-K · Annual report | Feb 25, 2026 | Annual report | SEC |
| 8-K · Current report | Feb 25, 2026 | Results | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 6, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 5, 2026 | Big-stake notice | SEC |
| 425 | Feb 4, 2026 | Other filings | SEC |
| 425 | Jan 20, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jan 16, 2026 | Insider trade | SEC |
| 425 | Jan 16, 2026 | Other filings | SEC |
| 425 | Jan 15, 2026 | Other filings | SEC |
| 425 | Jan 15, 2026 | Other filings | SEC |
| 425 | Jan 15, 2026 | Other filings | SEC |
| 425 | Jan 15, 2026 | Other filings | SEC |
| 425 | Jan 15, 2026 | Other filings | SEC |
| 425 | Jan 15, 2026 | Other filings | SEC |
| 8-K · Current report | Jan 15, 2026 | Results | SEC |
| 4 · Change in ownership | Jan 8, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jan 6, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jan 2, 2026 | Other filings | SEC |
| 4 · Change in ownership | Dec 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 9, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 3, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 2, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 25, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 25, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 21, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 6, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 5, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 5, 2025 | Results | SEC |
| 144 · Notice of proposed sale | Nov 4, 2025 | Other filings | SEC |
| 4 · Change in ownership | Oct 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 3, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 2, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 1, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 1, 2025 | Other filings | SEC |
| 4 · Change in ownership | Sep 16, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Sep 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 4, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 3, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 2, 2025 | Other filings | SEC |
| 8-K · Current report | Aug 27, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Aug 22, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 20, 2025 | Other filings | SEC |
| 4 · Change in ownership | Aug 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 13, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 13, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 13, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 12, 2025 | Other filings | SEC |
| 4 · Change in ownership | Aug 8, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 6, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Jul 29, 2025 | Quarterly report | SEC |
| 8-K · Current report | Jul 29, 2025 | Results | SEC |
| 4 · Change in ownership | Jul 25, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jul 23, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jul 11, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jul 9, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jul 3, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jul 1, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jun 27, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 27, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 25, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jun 18, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 16, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jun 13, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 11, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jun 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 30, 2025 | Insider trade | SEC |
| SD · Specialized disclosure | May 30, 2025 | ESG report | SEC |
| 8-K · Current report | May 30, 2025 | Meeting outcome | SEC |
| 144 · Notice of proposed sale | May 28, 2025 | Other filings | SEC |
| 4 · Change in ownership | May 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 16, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 15, 2025 | Other filings | SEC |
| 4 · Change in ownership | May 14, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 14, 2025 | Other filings | SEC |
| 4 · Change in ownership | May 9, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 7, 2025 | Other filings | SEC |
| 4 · Change in ownership | May 6, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 2, 2025 | Other filings | SEC |
| 4 · Change in ownership | Apr 29, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Apr 29, 2025 | Other filings | SEC |
| 4 · Change in ownership | Apr 25, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Apr 23, 2025 | Quarterly report | SEC |
| 8-K · Current report | Apr 23, 2025 | Results | SEC |
| 4 · Change in ownership | Apr 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 17, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Apr 16, 2025 | Other filings | SEC |
| ARS · Annual report to shareholders | Apr 16, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 16, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 16, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 4, 2025 | Insider trade | SEC |
| PRE 14A · Preliminary proxy statement | Apr 4, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 2, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Apr 2, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Apr 2, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Apr 1, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Apr 1, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 31, 2025 | Other filings | SEC |
| 4 · Change in ownership | Mar 27, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 21, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 19, 2025 | Other filings | SEC |
| 4 · Change in ownership | Mar 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 5, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 4, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 3, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 3, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 3, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 3, 2025 | Other filings | SEC |
| 8-K · Current report | Feb 21, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Feb 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 19, 2025 | Insider trade | SEC |
| 10-K · Annual report | Feb 18, 2025 | Annual report | SEC |
| 8-K · Current report | Feb 18, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 14, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Jan 6, 2025 | Insider trade | SEC |
This page holds 200 of 959 filings. Open Filings
Cap table
Built by 6ix from Penumbra, Inc.’s releases · as of Oct 14, 2026
- Common shares
- 39,414,385
- Fully diluted
- 39,414,385
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 39,414,385 | Oct 14, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Oct 14, 2026 | 39,414,385 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Harpreet Grewal Other companies: Constant Contact Inc (EVP, Chief Financial Officer · Jul 6, 2010 – Feb 9, 2016 · Past); Cimpress plc (Exec VP and CFO · Oct 2, 2006 – Jul 2, 2008 · Past) | Director · Since at least Sep 17, 2015 |
| Sridhar Kosaraju Other companies: 10x Genomics, Inc. (Member · Since at least Sep 11, 2019); Nevro Corp (Director · Aug 31, 2021 – Apr 3, 2025 · Past) | President · Sep 17, 2015 – Apr 15, 2020 · Past |
| Jason Mills Other companies: NeuroOne Medical Technologies Corporation (Director · Since at least Dec 18, 2025) | Executive Vice President, Strategy · Since at least Nov 5, 2026 |
| Maggie S. Yuen Other companies: AtriCure, Inc. (Director · Since at least Aug 7, 2026) | Chief Financial Officer · Since at least Nov 4, 2026 |
| Maggie Yuen Other companies: AtriCure, Inc. (Director · Since at least Jun 15, 2021) | Chief Financial Officer · Since at least Dec 2, 2019 |
| Thomas C. Wilder Other companies: Endologix Inc (Director · May 20, 2010 – Aug 12, 2020 · Past) | Director · Since at least Jan 13, 2017 |
| Adam Elsesser | Chairman and Chief Executive Officer · Since at least Sep 17, 2015 |
| Arani Bose | Director · Since at least Sep 17, 2015 |
| Ben Sorci | Executive Vice President, Operations · Since at least Nov 4, 2026 |
| Ben Tompkins | Executive Vice President, Development and Compliance · Since at least Nov 4, 2026 |
All 23 people
| Person | Seat |
|---|---|
| Bridget O'Rourke | Director · Since at least Apr 21, 2017 |
| Don W Kassing | Director · Sep 17, 2015 – Feb 14, 2025 · Past |
| James F. Benenati | Chief Medical Officer · Since at least Oct 20, 2026 |
| James Robert Pray | President, International · Sep 17, 2015 – Oct 1, 2021 · Past |
| Janet Leeds | Director · Since at least Jan 17, 2019 |
| Johanna Roberts | EVP, Gen. Counsel & Secretary · Since at least Apr 15, 2021 |
| Kevin James Sullivan | Director · Feb 23, 2016 – Aug 31, 2016 · Past |
| Lambert Shiu | Chief Accounting Officer · Since at least Dec 2, 2019 |
| Lynn Rothman | EVP and Chief Business Officer · Sep 17, 2015 – Oct 1, 2021 · Past |
| Robert D Evans | EVP, Gen. Counsel & Secretary · Sep 17, 2015 – Aug 29, 2018 · Past |
| Shruthi Narayan | President · Since at least Sep 1, 2025 |
| Surbhi Sarna | Director · Since at least Oct 2, 2023 |
| Walter Charles Wang | Director · Sep 17, 2015 – Mar 4, 2016 · Past |
Log in to ask 6ix AI your own questions about Penumbra, Inc.